[7B2-7B2];[7C1-7C1];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
7B2;7C1
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
The presence of P+PBac{XP5.WH5}BSC536 was verified using the PCR methods and primers described in FBrf0175003.
The cytological breakpoints of Df(1)BSC536 predicted from the Release 5 genomic coordinates of the progenitor PBac{WH}CBPf00211 and P{XP}d01377 transposable element insertion sites are 7B2;7C1.